130 related articles for article (PubMed ID: 36340517)
1. Persistent cross-species SARS-CoV-2 variant infectivity predicted via comparative molecular dynamics simulation.
Rajendran M; Babbitt GA
R Soc Open Sci; 2022 Nov; 9(11):220600. PubMed ID: 36340517
[TBL] [Abstract][Full Text] [Related]
2. Cross-species recognition of SARS-CoV-2 to bat ACE2.
Liu K; Tan S; Niu S; Wang J; Wu L; Sun H; Zhang Y; Pan X; Qu X; Du P; Meng Y; Jia Y; Chen Q; Deng C; Yan J; Wang HW; Wang Q; Qi J; Gao GF
Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33335073
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of SARS-CoV-2 and its variants binding to intermediate horseshoe bat ACE2.
Tang L; Zhang D; Han P; Kang X; Zheng A; Xu Z; Zhao X; Wang VY; Qi J; Wang Q; Liu K; Gao GF
Int J Biol Sci; 2022; 18(12):4658-4668. PubMed ID: 35874946
[TBL] [Abstract][Full Text] [Related]
4. A So-Far Overlooked Secondary Conformation State in the Binding Mode of SARS-CoV-2 Spike Protein to Human ACE2 and Its Conversion Rate Are Crucial for Estimating Infectivity Efficacy of the Underlying Virus Variant.
Sevenich M; van den Heuvel J; Gering I; Mohrlüder J; Willbold D
J Virol; 2022 Jul; 96(13):e0068522. PubMed ID: 35674432
[TBL] [Abstract][Full Text] [Related]
5. Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2.
Mou H; Quinlan BD; Peng H; Liu G; Guo Y; Peng S; Zhang L; Davis-Gardner ME; Gardner MR; Crynen G; DeVaux LB; Voo ZX; Bailey CC; Alpert MD; Rader C; Gack MU; Choe H; Farzan M
PLoS Pathog; 2021 Apr; 17(4):e1009501. PubMed ID: 33836016
[TBL] [Abstract][Full Text] [Related]
6. Insight into the origin of SARS-CoV-2 through structural analysis of receptor recognition: a molecular simulation study.
Sun J; Liu M; Yang N
RSC Adv; 2021 Feb; 11(15):8718-8729. PubMed ID: 35423354
[TBL] [Abstract][Full Text] [Related]
7. The
Li P; Guo R; Liu Y; Zhang Y; Hu J; Ou X; Mi D; Chen T; Mu Z; Han Y; Chen Z; Cui Z; Zhang L; Wang X; Wu Z; Wang J; Jin Q; Qian Z
Sci Bull (Beijing); 2021 Jun; 66(12):1215-1227. PubMed ID: 33495713
[TBL] [Abstract][Full Text] [Related]
8. Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant.
Schubert M; Bertoglio F; Steinke S; Heine PA; Ynga-Durand MA; Maass H; Sammartino JC; Cassaniti I; Zuo F; Du L; Korn J; Milošević M; Wenzel EV; Krstanović F; Polten S; Pribanić-Matešić M; Brizić I; Baldanti F; Hammarström L; Dübel S; Šustić A; Marcotte H; Strengert M; Protić A; Piralla A; Pan-Hammarström Q; Čičin-Šain L; Hust M
BMC Med; 2022 Mar; 20(1):102. PubMed ID: 35236358
[TBL] [Abstract][Full Text] [Related]
9. Species-Specific Molecular Barriers to SARS-CoV-2 Replication in Bat Cells.
Aicher SM; Streicher F; Chazal M; Planas D; Luo D; Buchrieser J; Nemcova M; Seidlova V; Zukal J; Serra-Cobo J; Pontier D; Pain B; Zimmer G; Schwartz O; Roingeard P; Pikula J; Dacheux L; Jouvenet N
J Virol; 2022 Jul; 96(14):e0060822. PubMed ID: 35862713
[TBL] [Abstract][Full Text] [Related]
10. Mutational landscape and in silico structure models of SARS-CoV-2 spike receptor binding domain reveal key molecular determinants for virus-host interaction.
Nelson-Sathi S; Umasankar PK; Sreekumar E; Nair RR; Joseph I; Nori SRC; Philip JS; Prasad R; Navyasree KV; Ramesh S; Pillai H; Ghosh S; Santosh Kumar TR; Pillai MR
BMC Mol Cell Biol; 2022 Jan; 23(1):2. PubMed ID: 34991443
[TBL] [Abstract][Full Text] [Related]
11. Computational optimization of the SARS-CoV-2 receptor-binding-motif affinity for human ACE2.
Polydorides S; Archontis G
Biophys J; 2021 Jul; 120(14):2859-2871. PubMed ID: 33984310
[TBL] [Abstract][Full Text] [Related]
12. Structural bioinformatics analysis of SARS-CoV-2 variants reveals higher hACE2 receptor binding affinity for Omicron B.1.1.529 spike RBD compared to wild type reference.
Durmaz V; Köchl K; Krassnigg A; Parigger L; Hetmann M; Singh A; Nutz D; Korsunsky A; Kahler U; König C; Chang L; Krebs M; Bassetto R; Pavkov-Keller T; Resch V; Gruber K; Steinkellner G; Gruber CC
Sci Rep; 2022 Aug; 12(1):14534. PubMed ID: 36008461
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 variants impact RBD conformational dynamics and ACE2 accessibility.
Valério M; Borges-Araújo L; Melo MN; Lousa D; Soares CM
Front Med Technol; 2022; 4():1009451. PubMed ID: 36277437
[TBL] [Abstract][Full Text] [Related]
14. Molecular insights into the binding variance of the SARS-CoV-2 spike with human, cat and dog ACE2 proteins.
Zang Y; Li X; Zhao Y; Wang H; Hao D; Zhang L; Yang Z; Yuan X; Zhang S
Phys Chem Chem Phys; 2021 Jun; 23(24):13752-13759. PubMed ID: 34132301
[TBL] [Abstract][Full Text] [Related]
15. Site Density Functional Theory and Structural Bioinformatics Analysis of the SARS-CoV Spike Protein and hACE2 Complex.
Kumawat N; Tucs A; Bera S; Chuev GN; Valiev M; Fedotova MV; Kruchinin SE; Tsuda K; Sljoka A; Chakraborty A
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164065
[TBL] [Abstract][Full Text] [Related]
16. Computational decomposition reveals reshaping of the SARS-CoV-2-ACE2 interface among viral variants expressing the N501Y mutation.
Socher E; Conrad M; Heger L; Paulsen F; Sticht H; Zunke F; Arnold P
J Cell Biochem; 2021 Dec; 122(12):1863-1872. PubMed ID: 34516024
[TBL] [Abstract][Full Text] [Related]
17. Comparative Structural Analysis of Human ACE2 Receptor with Spike Protein of SARS-CoV-2 Variants: Implications to Understand Infectivity of the Virus.
Koley T; Goswami A; Kumar M; Upadhyay N; Hariprasad G
Adv Appl Bioinform Chem; 2022; 15():21-27. PubMed ID: 35734581
[TBL] [Abstract][Full Text] [Related]
18. Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1.
Geng Q; Shi K; Ye G; Zhang W; Aihara H; Li F
J Virol; 2022 Apr; 96(8):e0024922. PubMed ID: 35343765
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
[TBL] [Abstract][Full Text] [Related]
20. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
Shi J; Zheng J; Tai W; Verma AK; Zhang X; Geng Q; Wang G; Guan X; Malisheni MM; Odle AE; Zhang W; Li F; Perlman S; Du L
J Virol; 2022 Sep; 96(17):e0011822. PubMed ID: 35972290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
